Steroid Protocol May Reduce Opioid Use After Wisdom Tooth Surgery
Event summary
- A study published in the Journal of Oral and Maxillofacial Surgery (JOMS) found that a single intravenous dose of dexamethasone reduced postoperative pain in patients undergoing wisdom tooth surgery.
- Patients receiving dexamethasone experienced less pain in the first 24 hours, regardless of whether they subsequently used opioid or non-opioid pain relievers.
- The combination of dexamethasone and non-opioid pain relievers resulted in the lowest overall pain scores during the recovery period.
- The research was supported by the multicenter Opioid Analgesic Reduction Study (OARS) and aligns with efforts to reduce opioid prescriptions.
The big picture
The study reinforces a broader trend toward multimodal pain management and a reduction in opioid prescriptions, driven by public health concerns and regulatory pressure. AAOMS's advocacy for non-opioid alternatives positions it as a key influencer in shaping surgical protocols and potentially reducing the risk of opioid-related complications. This research contributes to a growing body of evidence supporting alternative pain management strategies, which could significantly impact the oral surgery market and related pharmaceutical sales.
What we're watching
- Adoption Rate
- The speed at which oral surgeons adopt this steroid protocol will depend on factors like cost, perceived efficacy, and potential side effects, impacting AAOMS's influence on standard practice.
- Regulatory Scrutiny
- Increased adoption of dexamethasone could draw scrutiny from regulatory bodies regarding potential long-term effects or interactions, requiring further research and potentially impacting AAOMS's liability exposure.
- Cost Implications
- The broader implementation of this protocol will likely shift the cost burden of postoperative pain management, potentially impacting patient out-of-pocket expenses and influencing insurance coverage decisions.
Related topics